First Time Loading...
L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.4 GBX -3.52%
Updated: May 13, 2024
Section:
 

Wall Street
Price Targets

LABS Price Targets Summary
Life Science REIT PLC

Wall Street analysts forecast LABS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABS is 61.88 GBX with a low forecast of 45.45 GBX and a high forecast of 84 GBX.

LABS Lowest Forecast
Wall Street Target
45.45 GBX
18% Upside
LABS Average Forecast
Wall Street Target
61.88 GBX
61% Upside
LABS Highest Forecast
Wall Street Target
84 GBX
119% Upside
Lowest
Price Target
45.45 GBX
18% Upside
Average
Price Target
61.88 GBX
61% Upside
Highest
Price Target
84 GBX
119% Upside
Life Science REIT PLC Competitors:
Price Targets
PHP
Primary Health Properties PLC
7% Upside
LTC
LTC Properties Inc
1% Upside
THRL
Target Healthcare REIT PLC
25% Upside
IHR
Impact Healthcare REIT PLC
36% Upside
PHP
Primary Health Properties PLC
7% Upside
LTC
LTC Properties Inc
1% Upside
THRL
Target Healthcare REIT PLC
25% Upside
IHR
Impact Healthcare REIT PLC
36% Upside
CHCT
Community Healthcare Trust Inc
28% Upside
V
VHP
Vital Healthcare Property Trust
6% Upside
DOC
Physicians Realty Trust
13% Upside
VTR
Ventas Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Life Science REIT PLC

For the last 1 year the compound annual growth rate for Life Science REIT PLC's revenue is 27%. The projected CAGR for the next 3 years is 12%.

27%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Life Science REIT PLC

For the last 1 year the compound annual growth rate for Life Science REIT PLC's operating income is 96%. The projected CAGR for the next 3 years is 26%.

96%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Life Science REIT PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
LABS intrinsic value, competitors valuation, and company profile.
DCF Valuation
LABS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LABS stock valuation using valuation multiples.
Wall Street Estimates
LABS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LABS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LABS's stock price target?
Price Target
61.88 GBX

According to Wall Street analysts, the average 1-year price target for LABS is 61.88 GBX with a low forecast of 45.45 GBX and a high forecast of 84 GBX.

What is Life Science REIT PLC's Revenue forecast?
Projected CAGR
12%

For the last 1 year the compound annual growth rate for Life Science REIT PLC's revenue is 27%. The projected CAGR for the next 3 years is 12%.

What is Life Science REIT PLC's Operating Income forecast?
Projected CAGR
26%

For the last 1 year the compound annual growth rate for Life Science REIT PLC's operating income is 96%. The projected CAGR for the next 3 years is 26%.

ALPHA SPREAD
Join more than 136,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.